Clinical trial
The Urinary Microbiome Before and After Treatment With Intradetrusor Onabotulinum Toxin A Injection for Overactive Bladder
NCT04479709 is registered in ClinicalTrials.gov with MetroHealth Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Urinary Microbiome Before and After Treatment With Intradetrusor Onabotulinum Toxin A Injection for Overactive Bladder
- Lead sponsor
- MetroHealth Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- June 30, 2022
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder